Long-acting ACE inhibitor-induced angioedema.
Angioedema is a known adverse reaction of the angiotensin converting enzyme (ACE) inhibitors. Although current investigations are in progress, the exact pathogenesis of ACE inhibitor-induced angioedema is still unclear. Most cases of angioedema we have seen remitting from the short-acting ACE inhibitor, captopril, have presented with mild angioedema, controlled with antihistamines and glucocorticosteroids. In contrast, the angioedema induced by the long-acting ACE inhibitors have been serious. Our five patients developed angioedema from either lisinopril or enalapril. Three of five patients presented with severe angioedema requiring intubation, and one of these patients had a tracheostomy. One patient with a history of mild angioedema secondary to captopril subsequently required intubation for his enalapril-induced angioedema.
Bielory
L
L
Division of Allergy and Immunology, UMDNJ-New Jersey Medical School, Newark 07103-2714.
Lee
S S
SS
Holland
C L
CL
Jaker
M
M
D000368:Aged; D000369:Aged, 80 and over; D000799:Angioedema / Q000139:chemically induced*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D004656:Enalapril / Q000009:adverse effects* / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D017706:Lisinopril; D008297:Male; D008875:Middle Aged; D012131:Respiratory Insufficiency / Q000139:chemically induced
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D017706:Lisinopril